Although they cannot stop the progression of the disease, acetylcholinesterase inhibitors act by increasing brain levels of acetylcholine, which are decreased in AD due to degeneration of cholinergic neurons, especially in the forebrain [96]. This evidence concerns the gene ACHE and Alzheimer disease.